Strand Life Sciences Strengthens its Senior Management
8/26/2009 2:27:54 PM
August 26, 2009, Bangalore, India – Strand Life Sciences, Pioneers in Discovery
Research Informatics, is gearing up to capture growth opportunities by strengthening its
senior management team.
Strand today announced the appointment of François Mandeville as Executive Vice
President - Marketing, Technology and Strategy. In this role, François will be
responsible for setting Strand’s strategic agenda and priorities and for managing
Technology and Marketing activities for the company. François will also manage
Strand’s US and international operations.
"I am extremely pleased that Francois will be contributing to the vision and direction of
Strand at a time of explosive growth for the company," said Dr. Vijay Chandru,
Chairman and CEO, Strand Life Sciences. Francois has proven to be one of the
industry’s most innovative leaders, and we hope to tap his experience as we
aggressively expand Strand's offerings to existing and new markets.”
François is passionate about software businesses that transform technologies into
solutions. François joined Hewlett-Packard in Canada at the age of 17 in a position
especially created to allow him to work in HP’s then new PC and LaserJet businesses
while studying electrical engineering at Montréal’s Ecole Polytechnique. During
François’ 25 year journey at HP and Agilent, he and his teams pioneered new software
enabled solutions in HP’s computer, printer and medical businesses in Agilent’s
telecommunications testing, chemical analysis and life sciences businesses. François,
who is based in the San Francisco Bay Area, worked in Australia, Canada, Europe and
Asia and drove the launch of several software businesses, acquisitions and
partnerships that are at the core of Agilent’s leadership in life sciences.
About Strand Life Sciences
Strand Life Sciences – Pioneers in Discovery Research Informatics, is an innovative life
science informatics company. Strand has developed pioneering software technologies
with applications in pharmaceutical drug discovery. Over the years Strand has built
strong competencies and intellectual property in the areas of omics-based technologies,
bioinformatics, cheminformatics, predictive modeling, workflow and knowledge
With a deep understanding of the life sciences industry, commitment to innovation,
access to current and emerging technologies, mature development processes, global
resources and a proven track record, Strand provides discovery informatics solutions and
services and help its customers achieve their objectives.
Five of the top ten pharmaceutical companies, three of the top six biotechnology
companies, and numerous academic institutions across the globe, are part of Strand's
esteemed customer profile, who trust Strand for delivering solutions to complex
problems in life sciences research. Strand is a portfolio company of UTI Venture Funds,
Sequoia Capital, and MediBIC group (Japan).
For more information please visit www.strandls.com.